Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Plos One|March 30, 2011
Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyadsMashudu Madzivhandila, Peter V Adrian, Clare L Cutland, et al.Journal of Medical Microbiology|October 16, 2012
Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South AfricaMashudu Madzivhandila, Peter V Adrian, Clare L Cutland, et al.European Journal of Preventive Cardiology|April 6, 2017
HIV and risk of cardiovascular disease in sub-Saharan Africa: Rationale and design of the Ndlovu Cohort StudyAlinda Vos, Hugo Tempelman, Walter Devillé, et al.BMC Infectious Diseases|January 27, 2018
Case report: mechanisms of HIV elite control in two African womenYumna Moosa, Ramla F Tanko, Veron Ramsuran, et al.Vaccine|July 6, 2025
Humoral, T cell and immune gene expression responses to SARS-CoV-2 vaccination in a small group of children with previous MIS-CTimothy F Spracklen, Jonathan Day, Hamza Van Der Ross, et al.Biorxiv : the Preprint Server for Biology|January 27, 2021
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasmaConstantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, et al.Nature Medicine|March 3, 2021
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasmaConstantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, et al.Journal of Virology|July 22, 2022
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus VariantsThandeka Moyo-Gwete, Mashudu Madzivhandila, Nonhlanhla N Mkhize, et al.Clinical Immunology (Orlando, Fla.)|December 23, 2023
Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell responseClaire Butters, Ntombi Benede, Thandeka Moyo-Gwete, et al.Biorxiv : the Preprint Server for Biology|March 10, 2021
SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodiesThandeka Moyo-Gwete, Mashudu Madzivhandila, Zanele Makhado, et al.Pageof 2